ID: ALA5075047

Max Phase: Preclinical

Molecular Formula: C24H27ClF2N6O2

Molecular Weight: 504.97

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1c(Nc2ncc3cc(Cl)c(C4CCN([C@@H]5COC[C@@H]5O)CC4)cc3n2)cnn1[C@@H]1CC1(F)F

Standard InChI:  InChI=1S/C24H27ClF2N6O2/c1-13-19(10-29-33(13)22-8-24(22,26)27)31-23-28-9-15-6-17(25)16(7-18(15)30-23)14-2-4-32(5-3-14)20-11-35-12-21(20)34/h6-7,9-10,14,20-22,34H,2-5,8,11-12H2,1H3,(H,28,30,31)/t20-,21+,22-/m1/s1

Standard InChI Key:  FMKVFRKEOSUZOG-BHIFYINESA-N

Associated Targets(Human)

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Leucine-rich repeat serine/threonine-protein kinase 2 6390 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase c-TAK1 2532 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Atrial natriuretic factor 17 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Salmonella typhimurium 15756 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 504.97Molecular Weight (Monoisotopic): 504.1852AlogP: 4.05#Rotatable Bonds: 5
Polar Surface Area: 88.33Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.60CX Basic pKa: 7.48CX LogP: 3.33CX LogD: 2.99
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.54Np Likeness Score: -0.63

References

1. Keylor MH, Gulati A, Kattar SD, Johnson RE, Chau RW, Margrey KA, Ardolino MJ, Zarate C, Poremba KE, Simov V, Morriello GJ, Acton JJ, Pio B, Yan X, Palte RL, McMinn SE, Nogle L, Lesburg CA, Adpressa D, Lin S, Neelamkavil S, Liu P, Su J, Hegde LG, Woodhouse JD, Faltus R, Xiong T, Ciaccio PJ, Piesvaux J, Otte KM, Wood HB, Kennedy ME, Bennett DJ, DiMauro EF, Fell MJ, Fuller PH..  (2022)  Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.,  65  (1.0): [PMID:34967623] [10.1021/acs.jmedchem.1c01968]

Source